The electronic cigarette: A wolf in sheep’s clothing

Wiener Klinische Wochenschrift

Volumn 127, Issue 9-10, 2015, Pages 385-387

  Neuberger, Manfred ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aerosol; Electronic cigarette; Nicotine; Review

Indexed keywords

NICOTINE; SOLVENT; FLAVORING AGENT; PARTICULATE MATTER;

AEROSOL; ARTICLE; ELECTRONIC CIGARETTE; HUMAN; INHALER; SMOKING BAN; SMOKING CESSATION; TOBACCO INDUSTRY; ADOLESCENT; ADULT; ADVERSE EFFECTS; AUSTRIA; BEHAVIOR; CHILD; DECEPTION; PARTICULATE MATTER; PSYCHOLOGY; SMOKING; SOCIAL MARKETING; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AUSTRIA; CHILD; DECEPTION; ELECTRONIC CIGARETTES; FLAVORING AGENTS; HUMANS; INTENTION; NICOTINE; PARTICULATE MATTER; SMOKING; SMOKING CESSATION; SOCIAL MARKETING; SOLVENTS; TOBACCO INDUSTRY; YOUNG ADULT;

EID: 84938359500     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-015-0753-3     Document Type: Article

References (31)

1. Neuberger M. Recent recommendations endanger progress of tobacco control. (letter) Brit Med J. 2007;334:s16.
2. Bunnel RE, Agaku IT, Arrazola RA, et al. Intentions to smoke cigarettes among never-smoking U.S. middle and high school electronic cigarette users, National Youth Tobacco Survey, 2011–2013. Nicotine Tob Res. 2014; doi:10.1093/ntr/ntu166. Epub ahead of print.
3. http://www.cancer.ca/en/about-us/for-media/media-releases/quebec/2014/electronic-cigarette-study/?region=qc. Accessed 24 Oct. 2014.
4. Bjartveit K, Tverdal A. Health consequences of smoking 1–4 cigarettes per day. Tob Control. 2005;14(5):315–20.
5. Ginzel KH, Maritz GS, Marks DF, et al. Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol. 2007;12(2):215–24.
6. Grando SA. Connections of nicotine to cancer. Nat Rev Cancer. 2014;14(6):419–29.
7. Bavarva JH, Tae H, McIver L, Garner HR. Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes. Oncotarget. 2014;5:4788–98.
8. Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn J, Luch A. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol. 2014;88(7):1295–308.
9. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25(2):91–101.
10. Ballbè M, Martínez-Sánchez JM, Sureda X, et al. Cigarettes vs. e-cigarettes: passive exposure at home measured by means of airborne marker and biomarkers. Environ Res. 2014;135:76–80.
11. Cobb NK, Abrams DB. The FDA, e-cigarettes, and the demise of combusted tobacco. N Engl J Med. 2014;371(16):1469–71.
12. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133–9.
13. Trassierraa CV, Cardellini F, Buonannoa G, De Felice P. On the interaction between radon progeny and particles generated by electronic and traditional cigarettes. Atmos Environ. 2014. Epub ahead of print.
14. Park SJ, Walser TC, Perdomo C, et al. The effect of e-cigarette exposure on airway epithelial cell gene expression and transformation. Clin Cancer Res. 2014;20:B16
15. Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol. 2012;24:976–84.
16. Fuoco FC, Buonanno G, Stabile L, Vigo P. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ Pollut. 2014;184:523–9.
17. Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23(1):25–31.
18. Schober W, Szendrei K, Matzen W, et al. Use of electronic cigarettes impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health. 2014;217:628–37.
19. Ruprecht AA, De Marco C, Pozzi P, et al. Comparison between particulate matter and ultrafine particle emission by electronic and normal cigarettes in real-life conditions. Tumori. 2014;100(1):e24–7. doi:10.1700/1430.15833.
20. Neuberger M. Feinstaub und akutes Koronarsyndrom. Univers Inn Med. 2008;01:47–9.
21. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67–86.
22. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A. 2010;1217:7547–55.
23. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide.
24. Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol. 2014;278(1):9–15.
25. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest. 2012;141(4):1110–3.
26. Moline JM, Golden AL, Highland JH, Wilmarth KR, Kao AS. Health Effects, Evaluation of Theatrical Smoke, Haze and Pyrotechnics. Report. Equity-League Pension and Health Trust Funds, 2000.
27. Bhatnagar A, Whitsel LP, Ribisl KM, et al. Electronic cigarettes. A policy statement from the American Heart Association. Circulation. 2014;130:1418–36.
28. Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014;190(6):611–8.
29. Bundesamt für Sicherheit im Gesundheitswesen: http://www.basg.gv.at/fileadmin/_migrated/content_uploads/070427_Ruyan.pdf
30. European Parliament and Council: http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf.
31. http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf. Accessed 24 Oct. 2014.